Planned Parenthood of the Pacific Southwest has started offering an HIV prevention injection as part of its services, it was ...

President Donald Trump's budget proposal for fiscal year 2026 requests significant reductions to HIV prevention and ...

Over the past three decades, there have been amazing advances in treating and preventing HIV. Subscribe to our newsletter for ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The Makerere University–Johns Hopkins University Research Collaboration has announced ongoing studies aimed at extending the ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

State's Health Outreach and Prevention program will end June 30 after federal funding cuts to HIV outreach and prevention ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.